lysine has been researched along with Giant Cell Tumor of Bone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, W; Shi, J; Shi, L; Shi, X; Wen, H | 1 |
| Abe, K; Aiba, H; Hayashi, K; Higuchi, T; Miwa, S; Murakami, H; Rosario, M; Takeuchi, A; Taniguchi, Y; Tanzawa, Y; Tsuchiya, H; Yamamoto, N | 1 |
2 other study(ies) available for lysine and Giant Cell Tumor of Bone
| Article | Year |
|---|---|
Histone H3.3 G34 Mutations Alter Histone H3K36 and H3K27 Methylation In Cis.
Topics: Bone Neoplasms; Brain Neoplasms; Child; Epigenesis, Genetic; Giant Cell Tumor of Bone; Glioblastoma; HeLa Cells; Histones; Humans; Lysine; Methylation; Mutation | 2018 |
Pathogenesis of Osteosclerotic Change Following Treatment with an Antibody Against RANKL for Giant Cell Tumour of the Bone.
Topics: Adult; Alkaline Phosphatase; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Female; Giant Cell Tumor of Bone; Histones; Humans; Immunohistochemistry; Lysine; Male; Methylation; Microscopy, Fluorescence; Middle Aged; Osteocalcin; Osteogenesis; RANK Ligand | 2017 |